Fig. 1

Psoriatic skin lesions of a patient with Aicardi-Goutières syndrome 7/Singleton-Merten syndrome 1 before and under treatment with tofacitinib. Psoriatic rash on the knees before treatment A and after 3 weeks treatment with tofacitinib B. Ulcerating skin lesion and swelling of the left ankle before treatment C and after 3 weeks treatment with tofacitinib D. Psoriatic rash on the hands and fingers before treatment E and after 3 weeks treatment with tofacitinib F. Psoriatic rash and ulcerating skin lesion on the left elbow before treatment G and 2 months after resumed treatment with tofacitinib H. Skin lesions and swelling of the feet before treatment I and 2 months after resumed treatment with tofacitinib J